 |
|
|
| |
SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/- RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
|
| |
| |
Reported by Jules Levin
48th Annual Meeting of the European Association for the Study of the Liver, Amsterdam, The Netherlands, 25 April 2013
Kris V. Kowdley1, Eric Lawitz2, Fred Poordad2, Daniel E. Cohen3, David Nelson4, Stefan Zeuzem5, Gregory T. Everson6, Paul Kwo7, Graham R Foster8, Mark Sulkowski9, Wangang Xie3, Lois Larsen3, Amit Khatri3, Thomas Podsadecki3, Barry Bernstein3
1: Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA; 2: The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX; 3: AbbVie Inc., North Chicago IL; 4: University of Florida College of Medicine, Gainesville, FL; 5: J.W. Goethe University, Frankfurt, Germany; 6: University of Colorado Denver, Aurora, CO; 7: Indiana University, Indianapolis, IN; 8: Queen Marys University of London, Barts Health, London, United Kingdom; 9: Johns Hopkins University, Baltimore, MD
|
| |
|
|
|
|
|
